(Q50335610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mattias Höglund

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

Anna K Hagström-Andersson

17 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sigurdur Gudjonsson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Lindgren D

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Liedberg F

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chebil G

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Borg A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Månsson W

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

2685-2696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16532037%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209249

17 January 2020

exact match

0 references

cites work

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

Integrins as receptors for laminins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Bladder cancer outcome and subtype classification by gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Identifying distinct classes of bladder carcinoma using microarrays.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

The long-term outcome in patients with superficial transitional cell carcinoma of the bladder: a single-institutional experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Exploring expression data: identification and analysis of coexpressed genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Identification of novel bladder tumour suppressor genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Molecular analysis of transitional cell carcinoma using cDNA microarray

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

TM4: a free, open-source system for microarray data management and analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Gene discovery in bladder cancer progression using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021

Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209249

7 January 2021